AI agents for therapeutic reasoning across biological contexts

Michelle M. Li examines how computational analyses can preserve the biological context of a proposed treatment, including cell type, disease state, genetic background and patient characteristics. She introduces Medea, an AI system that combines biological software, predictive models and literature retrieval while checking intermediate steps and reconciling evidence.

The seminar presents evaluations involving cell-specific target selection, cancer-cell synthetic lethality and immunotherapy response. A separate yeast experiment tests predictions against previously unpublished measurements of gene-pair interactions under DNA-damaging treatments. The research addresses whether an agent can transfer useful evidence between contexts while recognizing when that transfer is unsupported. Reported comparisons cover predictive performance, computational failures and the ability to abstain. This recording retains the original seminar date.